Policy & Regulation
Nona Biosciences names new chief operating officer
3 July 2026 - Global biotechnology company Nona Biosciences announced on Thursday the appointment of Dr. Peng Wang as its new chief operating officer (COO).Dr. Wang will be based in Suzhou and will re...
SK bioscience to lead Gates Foundation-funded ROTOR project
3 July 2026 - SK bioscience, a South Korea-based vaccine and biotech company, announced on Thursday that it will lead the Research Optimization & Trial Outcome Recommender (ROTOR) project, an AI-p...
Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology
3 July 2026 - Integrated biotechnology company Partner Therapeutics Inc (PTx) reported on Thursday that results from the cholangiocarcinoma cohort of the eNRGy trial have been published in the Journal...
Arcturus Therapeutics and Thermo Fisher enter strategic collaboration on ARCT-032 development
2 July 2026 - Messenger RNA medicines company Arcturus Therapeutics Holdings Inc (Nasdaq:ARCT) announced on Thursday that it has entered into a strategic collaboration with Thermo Fisher Scientific In...
Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer
2 July 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Thursday reported positive Phase III results from the Krascendo 1 trial evaluating investig...
Neurocrine Biosciences initiates crinecerfont Phase 2 study in young children with classic CAH
2 July 2026 - Biopharmaceutical company Neurocrine Biosciences Inc (Nasdaq:NBIX) announced on Wednesday the initiation of its Phase 2 clinical study to assess the safety and tolerability of crinecerfo...